Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations

Completed · Phase 1

Conditions studied: Pharmacokinetic Study in Healthy Participants

In brief

The purpose of the study is to compare the blood levels of dasatinib in healthy participants who received tablet formulation with those of healthy participants who received liquid and tablet-dispersed formulations of the drug.

Key facts

Study ID

NCT01392703

Run by

Bristol-Myers Squibb

People needed

141

Starts

2011-07-01

Expected to finish

2011-09-01

Last updated by the study team

2013-02-11

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Healthcare Discoveries Inc. — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.